Lok Sabha Question No. 1212 (UNSTARRED), answered on 2026-02-06
Subject: Quality of AYUSH Medicine
Ministry: AYUSH
Asked by: Shri Rajpalsinh Mahendrasinh Jadav, Shri Jashubhai Bhilubhai Rathva

## GOVERNMENT OF INDIA MINISTRY OF AYUSH LOK SABHA UNSTARRED QUESTION NO. 1212 TO BE ANSWERED ON 6 th  FEBRUARY 2026

## ' Quality of AYUSH Medicine '

## 1212. Shri Jashubhai Bhilubhai Rathva: Shri Rajpalsinh Mahendrasinh Jadav:

Will the Minister of Ayush be pleased to state:

- (a) the manner in which the AYUSH Grid platforms, A-HMIS and e-Aushadhi have improved efficiency and transparency since their applications;
- (b) the outcomes achieved through AYUSH  Telemedicine and e-Sanjeevani integration in expanding healthcare access in remote and deprived areas;
- (c) the manner in which the Government is ensuring quality control and standardisation of AYUSH medicines through labs and testing protocols; and
- (d) the manner in which the PM Gati Shakti AYUSH Asset Mapping Tool is being used  to  optimise  the  planning  and  placement  of  hospitals,  colleges  and  research centres?

## ANSWER

## THE MINISTER OF STATE (IC) OF THE MINISTRY OF AYUSH (SHRI PRATAPRAO JADHAV)

- (a) The Ayush Grid project, launched by the Ministry of Ayush, serves as a comprehensive digital backbone for the Ayush sector, with the objective of strengthening service delivery across healthcare, research and development, education and awareness, drug administration, capacity building and medicinal plants. Under this initiative, multiple digital platforms including Ayush Hospital Management Information  System  (A-HMIS)  and  e-Aushadhi  have  been  developed.  The  A-HMIS has  been  adopted  by  Ayush  facilities  to  enhance  patient  care,  improve  operational efficiency and support data-driven decision-making. It standardises diagnostics, treatment workflows and service delivery, thereby improving institutional accountability and transparency.

e-Aushadhi is an IT enabled online portal to grant license to and/or renew the license of  the  manufacturers  to  manufacture  Ayurveda,  Siddha,  Sowa-Rigpa,  Unani  and Homoeopathy medicines by their respective State (Ayush) Licensing Authorities, as per  the  provisions  of  Drugs  and  Cosmetics  Act,  1940  and  Drugs  Rules,  1945.  The portal helps in facilitating paperless processing and tracking of the applications.

- (b) eSanjeevani and Ayush telemedicine platforms have been designed to be inclusive and accessible  platforms,  providing  free  teleconsultation  services  to  all. Ayush  services delivered  through  these  platforms  have  expanded  healthcare  access  in  remote  and under-served  areas  by  operationalising  Ayush  OPDs. The  services  are  operational across all states and Union Territories of India. These measures have improved access to  consultations  through  last-mile  service  delivery,  supported  continuity  of  care through digital workflows, reduced patient burden & costs, and enabled more efficient utilisation of Ayush specialists across multiple locations.
- (c) The steps being taken by the Ministry to ensure Quality Control and standardisation of AYUSH drugs through laboratories and testing protocols are as follows:
- The  Drugs  &  Cosmetics  Act,  1940  and  Drugs  Rules,  1945  have  exclusive regulatory provisions for Ayurvedic, Siddha, Sowa-Rigpa, Unani and Homoeopathy  drugs.  Provisions  relating  to  Ayurveda,  Siddha,  Sowa-Rigpa  and Unani  Drugs  are  contained  in  Chapter  IVA  and  Schedule-  I  of  the  Drugs  and Cosmetics  Act,  1940  and  in  Rules  151  to  169,  Schedules  E(I),  T  &  TA  of  the Drugs Rules, 1945. Further, second schedule (4A) of the Drugs and Cosmetics Act, 1940 provides standards for Homoeopathic drugs and  Rules 2dd, 30AA, 67 (C-H), 85 (A to I), 106-A, Schedule K, Schedule M-I of the Drugs Rules, 1945 pertain to Homoeopathic  drugs.  It  is  mandatory  for  the  manufacturers  to  adhere  to  the prescribed requirements for licensing of manufacturing units &  medicines including proof of safety & effectiveness, compliance with the Good Manufacturing  Practices  (GMP)  as  per  Schedule  T  &  Schedule  M-I  of  Drugs Rules, 1945 and quality standards of drugs given in the respective pharmacopoeia.
- Pharmacopoeia  Commission  for  Indian  Medicine  &  Homoeopathy  (PCIM&H), sub-ordinate  organization  under  Ministry  of  Ayush,  lays  down  the  formulary specifications  and  pharmacopoeial  standards  for  Ayurveda,  Siddha,  Unani  and Homoeopathy (ASU&H) drugs which serves as official compendia for ascertaining the quality (identity, purity and strength) of the ASU&H drugs. As per the Drugs & Cosmetics Act, 1940 and rules there under, the compliance to this quality standards are mandatory for manufacturing of ASU&H drugs.
- PCIM&H  also  acts  as  the  Appellate  Drugs  Testing  Laboratory  for  testing  or analysis of ASU&H Drugs. In addition, it conducts capacity-building trainings at regular intervals for the standardization, quality control, and testing or analysis of ASU&H drugs for Drug Regulatory Authorities, Drug Analysts, and other relevant stakeholders,  with  a  focus  on  laboratory  techniques  and  methodologies  essential for ensuring the quality of ASU&H drugs.
- Rule 160 A to J of the Drugs Rules, 1945 provides the regulatory guidelines for approval of Drug Testing Laboratory for carrying out such tests of identity, purity, quality  and  strength  of  Ayurvedic,  Siddha  and  Unani  drugs  as  may  be  required under  the  provisions  of  these  rules,  on  behalf  of  licensee  for  manufacture  of Ayurvedic, Siddha and Unani drugs. As  on date, 34 State Drug  Testing Laboratories  have  been  supported  for  strengthening  their  infrastructural  and functional  capacity.  Further,  108  laboratories  are  approved  or  licensed  under  the provisions  of  Drugs  Rules,  1945  for  quality  testing  of  Ayurvedic,  Siddha  and Unani drugs and raw materials.
- Ministry of Ayush has established an Ayush vertical in the Central Drugs Standard Control Organisation (CDSCO),  which  includes posts of 1 Deputy Drugs Controller, 4 Assistant Drugs Controllers, and 4 Drugs Inspectors. Drugs Inspectors  posted  in  Ayush  vertical,  inspect  various  manufacturing  units  in coordination with the licensing authorities/drugs inspectors of respective States/Union Territories for ensuring safety and quality of Ayush medicines.
- (d) A dedicated app for mapping of Ayush assets have been developed with the name 'PM GatiShakti Ayush Asset Mapping Tool'. The app is being used to map the Ayush  health  facility,  educational  institutes,  research  centres  etc.  using  exact latitude  and  longitude  of  the  asset  helping  further  planning  of  establishing  new Ayush facility/college etc.

*****